Potential Uses for Cord Blood Mesenchymal Stem Cells

Zarrabi, Morteza; Mousavi, Seyed Hadi; Abroun, Saeid; Sadeghi, Bahareh
December 2013
Cell Journal (Yakhteh);Winter2014, Vol. 15 Issue 4, p274
Academic Journal
Stem cell therapy is a powerful technique for the treatment of a number of diseases. Stem cells are derived from different tissue sources, the most important of which are the bone marrow (BM), umbilical cord (UC) blood and liver. Human UC mesenchymal stem cells (hUC-MSCs) are multipotent, non-hematopoietic stem cells that have the ability to self-renew and differentiate into other cells and tissues such as osteoblasts, adipocytes and chondroblasts. In a number of reports, human and mouse models of disease have hUC-MSCs treatments. In this article, we review studies that pertain to the use of hUC-MSCs as treatment for diseases.


Related Articles

  • The Heterogeneous HLA Genetic Makeup of the Swiss Population. Buhler, Stéphane; Nunes, José Manuel; Nicoloso, Grazia; Tiercy, Jean-Marie; Sanchez-Mazas, Alicia // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    This study aims at investigating the HLA molecular variation across Switzerland in order to determine possible regional differences, which would be highly relevant to several purposes: optimizing donor recruitment strategies in hematopoietic stem cell transplantation (HSCT), providing reliable...

  • Mesenchymal Stromal Cells from Umbilical Cord Blood. Bieback, Karen; Kl�ter, Harald // Current Stem Cell Research & Therapy;Dec2007, Vol. 2 Issue 4, p310 

    Mesenchymal Stromal Cells (MSC) are key candidates for cellular therapies. Although most therapeutic applications have focused on adult bone marrow derived MSC, increasing evidence suggests that MSC are present within a wide range of tissues. Umbilical cord blood (CB) has been proven to be a...

  • Repairing Damaged Goods: Mesenchymal Stromal Cell Therapy for Secondary Failure of Hematopoiesis Post-Allogeneic Hematopoietic Cell Transplant. Holtan, Shernan G.; Newell, Laura F.; Chandran, Rekha; Markovic, Svetomir N.; Porrata, Luis F. // Journal of Stem Cell Research & Therapy;2012, Vol. 2 Issue 5, Special section p1 

    The authors examine the efficacy of mesenchymal stromal cell therapy for secondary failure of hematopoiesis post-allogeneic hematopoietic cell transplant (HCT). They explore the potential of HCT to cure high-risk or advanced cancers of the blood such as acute leukemia. They suggest, however, the...

  • Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Plock, Jan A.; Schnider, Jonas T.; Schweizer, Riccardo; Gorantla, Vijay S.; Bondanza, Attilio; Biagi, Ettore // Frontiers in Immunology;Feb2013, Vol. 4, Special section p1 

    The article discusses a study by E. Eggenhofer and colleagues published in an issue of "Frontiers in Immunology" on the role of cultured mesenchymal stromal cells (MSCs) in immunomodulation in transplantation. The researchers presented evidence in a mouse model that cultured bone-marrow derived...

  • Hydrodynamic loading in concomitance with exogenous cytokine stimulation modulates differentiation of bovine mesenchymal stem cells towards osteochondral lineages. Goldman, Stephen M.; Barabino, Gilda A. // BMC Biotechnology;2/1/2016, Vol. 16, p1 

    Background: Mesenchymal stem cells (MSCs) are viewed as a having significant potential for tissue engineering and regenerative medicine therapies. Clinical implementation of MSCs, however, demands that their preparation be stable and reproducible. Given that environmental and bioprocessing...

  • ParacrineMolecules ofMesenchymal Stem Cells for Hematopoietic StemCell Niche. Tian Li; Yaojiong Wu // Bone Marrow Research;2011, p1 

    Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are both adult stem cells residing in the bone marrow. MSCs interact with HSCs, they stimulate and enhance the proliferation of HSCs by secreting regulatory molecules and cytokines, providing a specialized microenvironment for...

  • Plasticity and Maintenance of Hematopoietic Stem Cells During Development. Kanji, Suman; Pompili, Vincent J.; Das, Hiranmoy // Recent Patents on Biotechnology;Apr2011, Vol. 5 Issue 1, p40 

    Maintenance of hematopoietic stem cells (HSCs) pool depends on fine balance between self-renewal and differentiation of HSCs. HSCs normally reside within the bone marrow niche of an adult mammal. The embryonic development of HSCs is a complex process that involves the migration of developing...

  • Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes. Poloni, A; Maurizi, G; Mattiucci, D; Amatori, S; Fogliardi, B; Costantini, B; Mariani, M; Mancini, S; Olivieri, A; Fanelli, M; Leoni, P // Leukemia (08876924);Nov2014, Vol. 28 Issue 11, p2241 

    The article focuses on the evidence that changes to the direct interaction between hematopoietic stem cells (HSCs) and stroma contribute to abnormal HSC growth and maturation. The use of flow cytometry to compare the expression of molecules that have important functions in cell adhesion such as...

  • Isolation and characterization of mesenchymal stem cells from human bone marrow. Qing Cong; Yan Xu; Yinghuang Wang; Wei Jiang; Yisheng Wang; Bin Li; Congjian Xu // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p12904 

    Objective: Human bone marrow mesenchymal stem cells (BMSCs) offer therapeutic potential for a broad range of diseases. Different approaches for the isolation of human BMSCs have been described, including the simple removal of non-adherent cells after 48 hours, density gradient centrifugation,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics